TH154310A - Inhibition of protein expression; Rev-interacting (hRIP) - Google Patents

Abstract

DC60 (15/10/15) This invention relates to the inhibition of protein expression. Rev-interacting (hRIP) consisting of a vector designed to allow the microRNA created in the laboratory to glow. When miRNA is expressed inside the cell and used to make miRNA that can be inhibited in multiple genes simultaneously within the cell, Which the vector can create a prototype cell The miRNA can be expressed at any time when it is stimulated without the need for a transformation vector. The vector generated in this invention destroys approximately 2 times or 50% of intracellular hRIPmRNA. Revised 10/15/2015 This invention relates to the inhibition of protein expression. Rev-interacting (hRIP) consisting of a vector designed to allow the microRNA created in the laboratory to glow. When miRNA is expressed inside the cell and used to make miRNA that can be inhibited in multiple genes simultaneously within the cell, Which the vector can create a prototype cell The miRNA can be expressed at any time when it is stimulated without the need for a transformation vector. The vector created in this invention can destroy approximately 2 times or 50% of the intracellular hRIPmRNA. ----------------------------- -------------------------------------------------- The invention relates to a method to inhibit HIV multiplication by inhibiting the expression of human Rev-interacting protein (hRIP) containing A vector designed to allow the generated microRNA to be light when expressed as intracellular miRNA and used to generate inhibitory miRNA in many ways. A gene simultaneously within the cell, the vector is able to generate cell lines that can be expressed as miRNA over time when stimulated. Without needing Thus, the miR expression vector generated in this invention can destroy approximately 2 times or 50% of the cellular hRIPmRNA, thus interfering with the HIV life cycle and being developed to treat HIV infection. IV got a patent for the drug

Claims (2)

: DC60 (15/10/15) This invention relates to the inhibition of protein expression. Rev-interacting (hRIP) consisting of a vector designed to allow the microRNA created in the laboratory to glow. When miRNA is expressed inside the cell and used to make miRNA that can be inhibited in multiple genes simultaneously within the cell, Which the vector can create a prototype cell The miRNA can be expressed at any time when it is stimulated without the need for a transformation vector. The vector generated in this invention destroys approximately 2 times or 50% of intracellular hRIPmRNA. Revised 10/15/2015 This invention relates to the inhibition of protein expression. Rev-interacting (hRIP) consisting of a vector designed to allow the microRNA created in the laboratory to glow. When miRNA is expressed inside the cell and used to make miRNA that can be inhibited in multiple genes simultaneously within the cell, Which the vector can create a prototype cell The miRNA can be expressed at any time when it is stimulated without the need for a transformation vector. The vector created in this invention can destroy approximately 2 times or 50% of the intracellular hRIPmRNA. ----------------------------- -------------------------------------------------- The invention relates to a method to inhibit HIV multiplication by inhibiting the expression of human Rev-interacting protein (hRIP) containing A vector designed to allow the generated microRNA to be light when expressed as intracellular miRNA and used to generate inhibitory miRNA in many ways. A gene simultaneously within the cell, the vector is able to generate cell lines that can be expressed as miRNA over time when stimulated. Without needing Thus, the miR expression vector generated in this invention can destroy approximately 2 times or 50% of the cellular hRIPmRNA, thus interfering with the HIV life cycle and being developed to treat HIV infection. IV has a claim (Item one) which will appear on the advertisement page: edit 15/10/15 1. Process of inhibition of protein expression. Rev-interacting (hRIP) consists of a method for generating human Rev-interacting mRNA-specific expression miR (hRIP) in the laboratory. Determination of Optimal Conditions for MiRNA Expression Vector Expression Inside a hila cell in the laboratory And determination of optimal conditions for expression of miR / hRIP expression vector in the laboratory. 2. Process of inhibition of protein expression. In Claim No. 1, where miR Expression Vector memorized: patent drug